ADVANCED PERITONEAL MALIGNANT MESOTHELIOMA

Clinical trials for ADVANCED PERITONEAL MALIGNANT MESOTHELIOMA explained in plain language.

Never miss a new study

Get alerted when new ADVANCED PERITONEAL MALIGNANT MESOTHELIOMA trials appear

Sign up with your email to follow new studies for ADVANCED PERITONEAL MALIGNANT MESOTHELIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New hope for Tough-to-Treat cancers: experimental drug aims to boost chemo power

Disease control Ongoing

This study is testing a new oral drug called TRC102 (methoxyamine) to see if it can make standard chemotherapy drugs more effective against advanced solid tumors and mesothelioma. It aims to find the safest dose and see if the combination can shrink tumors in patients whose cance…

Matched conditions: ADVANCED PERITONEAL MALIGNANT MESOTHELIOMA

Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Apr 01, 2026 14:42 UTC

ADVANCED PERITONEAL MALIGNANT MESOTHELIOMA

Get alerted when new ADVANCED PERITONEAL MALIGNANT MESOTHELIOMA trials appear

New hope for Tough-to-Treat cancers: experimental drug aims to boost chemo power